Tags: Drug.

Afatinib (INN; trade name Gilotrif in the US and Giotrif in Europe previously Tomtovok and Tovok) is a drug approved in much of the world (including the United States Canada the United Kingdom and Australia) for the treatment of metastatic non-small cell lung carcinoma (NSCLC) developed by Boehringer Ingelheim. It acts as an angiokinase inhibitor.

Afatinib2DACS.svg
ATC prefix
L01
ATC suffix
XE13
Bioavailability
92.0
CAS number
439081-18-2
ChEBI
61390
FDA UNII code
41UD74L59M
IUPAC name
N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4(dimethylamino)-2-butenamide
PubChem
10184653

Loading...

This page contains content from the copyrighted Wikipedia article "Afatinib"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.